The British Minister of Health made ominous predictions about the effectiveness of the vaccines against the “South African mutation” of the coronavirus in a “closed” teleconference with travel agents – He thought that his words would not be made public
The South African coronavirus mutation could reduce the effectiveness of vaccines by 50%, said British Health Minister Matt Hancock. In fact, the minister said that if the widespread transmission of this mutation to Britain was allowed, it could destroy the country’s vaccination program.
- Brief Anger Hampers Blood Vessel Function Leading to Increased Risk of Heart Disease and Stroke – New Study
- New Blood Test Pinpoints Future Stroke Risk – Study Identifies Inflammatory Molecules as Key Biomarker
- Enceladus: A Potential Haven for Extraterrestrial Life in its Hidden Ocean Depths
- New Experiment: Dark Matter Is Not As ‘DARK’ As All We Think
- Scientists in Fear of This New Predator From Red Sea Eating Native Species in Mediterranean
According to the Daily Mail, which released the relevant video, the minister made the relevant reports in a teleconference with travel agents during the week – shocking his audience. However, Hancock made it clear shortly afterwards that this was preliminary information – to add “I would not say this in public“.
The South African mutation has differences in the “protein spike”, leading scientists to fear that the immune system of people who have been vaccinated could not recognize – and fight.
The alarming reports from the British Ministry of Health come after scientists in South Africa found that 48% of blood samples from people who had been infected with the “original” coronavirus and therefore had developed antibodies did not show any reaction to the mutant virus.
It is noted that the “South African mutation” of the virus is considered more contagious than the “British mutation”. In Britain, 73 cases of “South African mutation” have been identified so far – although it is suspected that its transmission may already be much higher, as only 10% of positive samples are tested in laboratories to find out which mutation the virus belongs to.
